The first Atea Pharmaceuticals trade was made in Q2 2021.
Since then Joel Greenblatt bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q2 2022 and Q4 2022.
Avg closing price
Price range
Sold -11.4 Thousand shares
Q4 2022
Avg closing price
$5.06
Price range
$4.35
-
$6.06
Sold 48.2% shares (-10.6 Thousand shares)
Q3 2022
Avg closing price
$7.65
Price range
$5.49
-
$8.79
Sold 29.4% shares (-9.2 Thousand shares)
Q2 2022
Avg closing price
$6.83
Price range
$5.33
-
$8.18
Increased shares by 7.1% (+2.07 Thousand shares)
Q1 2022
Avg closing price
$6.79
Price range
$5.50
-
$9.19
Sold 33.8% shares (-14.9 Thousand shares)
Q4 2021
Avg closing price
$15.58
Price range
$7.67
-
$44.59
Increased shares by 97.2% (+21.7 Thousand shares)
Q3 2021